tebnow← All categories
Category

Health Tech

947 articles indexed

CVS Caremark Settles with FTC, Promises Changes to Insulin Pricing Practices

CVS Health's Caremark has reached a significant settlement with the Federal Trade Commission (FTC) aimed at reforming its pharmacy benefit management practices, particularly concerning insulin pricing. The FTC's allegations claimed that Caremark favored higher-cost insulin products to secure larger rebates, ultimately increasing costs for consumers. This settlement, announced on Tuesday, mandates that Caremark prioritize lower-cost drugs in its formularies and pass on savings negotiated with drug manufacturers to clients. The FTC estimates that these changes could save consumers up to $8.5 billion over the next decade, with an additional $4.5 billion in savings from rebates applied at the point of sale. The settlement aligns closely with a previous agreement made by Express Scripts, another major pharmacy benefit manager, while Optum Rx is still in negotiations with the FTC. The reforms are particularly crucial as Caremark, Express Scripts, and Optum Rx collectively manage around 80% of U.S. prescriptions, meaning their operational changes could significantly impact drug pricing and accessibility for millions of patients. The agreement also includes provisions to enhance transparency and prevent Caremark from obstructing independent pharmacies from collaborating with competing pharmacy hubs. Despite the anticipated consumer benefits, the settlement does not impose financial penalties on Caremark, and analysts suggest that the company, along with its peers, has already been moving towards rebate-free models in response to increasing regulatory scrutiny. CVS has expressed that this settlement allows them to focus on delivering value to consumers and employers while enhancing affordability and transparency in healthcare. The changes are expected to reshape the pharmacy benefits landscape, potentially alleviating some of the financial burdens faced by patients requiring essential medications like insulin.

Healthcare Dive/1d ago

CVS Health / FTC / pharmacy benefit managers / insulin pricing / healthcare reform

HCA Healthcare Lowers 2026 Earnings Forecast Amid Rising Uninsured Rates

HCA Healthcare has revised its 2026 earnings guidance downward due to significant losses attributed to a shift in payer mix, primarily stemming from a rise in uninsured Americans. The company reported a $400 million loss in the second quarter, largely linked to individuals dropping out of Affordable Care Act (ACA) plans after the expiration of enhanced federal financial aid. This adjustment has led HCA to now anticipate a net income between $6.3 billion and $6.7 billion for the year, down from an earlier estimate of $6.5 billion to $7 billion. The impact of the ACA turmoil has raised concerns among investors, resulting in a nearly 10% drop in HCA's stock during premarket trading. This decline also affected other hospital operators, including Community Health Systems, Tenet Healthcare, and Universal Health Services. Experts indicate that millions of Americans have lost coverage, contributing to a worrying trend of increased uninsured rates, which poses challenges for hospitals facing lower demand for elective services and rising uncompensated care costs. HCA had initially projected losses of $600 million to $900 million due to the ACA's effects but has now adjusted that figure to potentially reach up to $1.1 billion. The company also noted a decline in surgical volumes during the second quarter, which likely influenced its decision to lower earnings expectations. Despite these challenges, HCA anticipates stronger overall second-quarter results compared to the previous year, with expected revenues of approximately $20.2 billion, an increase from $18.6 billion, and a net income just below $1.7 billion. The official announcement of second-quarter results is scheduled for July 24, 2026.

Healthcare Dive · 1d ago

MPs Demand Clarity on Palantir's Future in NHS Amid Contract Concerns

The ongoing scrutiny of Palantir's role in the NHS has intensified, with Members of Parliament (MPs) pressing for answers regarding the future of the company's contract for the Federated Data Platform (FDP). Jon Hoeksma, a prominent commentator on health technology, suggests that the focus has shifted from whether the contract will be terminated to the timing and manner of its potential cessation. This development is significant as it reflects growing concerns over data privacy and the ethical implications of using private companies in public health systems. Stakeholders, including healthcare professionals and policymakers, are closely monitoring the situation, as the outcome could impact data management strategies within the NHS. As discussions continue, the NHS must navigate the complexities of data governance while ensuring that patient care remains a priority.

Digital Health · 1d ago

Innovative Tools Enhance Breast Cancer Detection and Paramedic Efficiency

In today's digital health briefing, two significant advancements were highlighted: a new tool for breast cancer detection utilizing magnetic resonance imaging (MRI) and a mobile electronic patient record (EPR) system designed to streamline paramedic operations. The MRI tool aims to improve early detection rates of breast cancer, which is crucial for effective treatment and better patient outcomes. Early detection can significantly reduce mortality rates associated with breast cancer, making this technology a vital addition to diagnostic practices. The mobile EPR system is set to alleviate the administrative burden on paramedics, allowing them to focus more on patient care rather than paperwork. By enabling real-time access to patient records and streamlining data entry, this tool could enhance the efficiency of emergency medical services. The integration of such technology is particularly important in emergency situations where time is critical. These innovations not only represent advancements in medical technology but also underscore the ongoing efforts to improve healthcare delivery and patient outcomes. As these tools are implemented, healthcare professionals will need to adapt to new workflows and ensure that they are effectively utilized in clinical settings. The potential impact on patient care and operational efficiency could be substantial, paving the way for further developments in digital health solutions.

Digital Health · 1d ago

NHS England Accelerates AI Tool Rollout, Health Sector Responds Cautiously

NHS England has announced an accelerated rollout of artificial intelligence (AI) tools across the healthcare sector, a move that has garnered cautious optimism from various stakeholders. The integration of AI technologies is expected to enhance efficiency, improve patient outcomes, and streamline operations within the NHS. However, healthcare professionals express concerns regarding the implications of AI on patient care and the potential for over-reliance on technology. The rollout aims to address pressing challenges within the NHS, including staffing shortages and increasing patient demand. By leveraging AI, the NHS hopes to optimize resource allocation and improve diagnostic accuracy. Key figures in the health sector have highlighted the importance of ensuring that AI tools are rigorously tested and validated before widespread implementation to safeguard patient safety. As the initiative progresses, stakeholders are closely monitoring its impact on healthcare delivery and patient experiences. The success of this AI integration will depend on ongoing collaboration between technology developers, healthcare providers, and regulatory bodies to ensure that the tools meet the needs of both patients and practitioners. The next steps will involve pilot programs and feedback mechanisms to assess the effectiveness of these AI solutions in real-world settings.

Digital Health · 1d ago

HHS Targets Medicaid and Medicare Advantage Fraud with New Enforcement Actions

The U.S. Department of Health and Human Services (HHS) has intensified its efforts to combat fraud in federal healthcare programs, particularly Medicaid and Medicare Advantage. According to a recent report from the HHS Office of Inspector General (OIG), the agency has removed over 1,200 individuals and entities from federal programs and generated approximately $5.6 billion in monetary impact from its fraud prevention initiatives between October and March. This report, which is submitted to Congress biannually, underscores the Trump administration's commitment to addressing what it describes as widespread fraud in healthcare. Key enforcement actions highlighted in the report include significant criminal and civil cases, such as a Medicare telemarketing fraud scheme that resulted in a 15-year prison sentence for the CEO of Power Mobility Doctor Rx. Additionally, a mother and daughter duo was ordered to pay over $3.6 million for a Medicaid fraud scheme in Maryland, which involved billing for behavioral care services that were never provided. The report also emphasizes the scrutiny surrounding autism services, particularly in applied behavior analysis therapy, where clinics have been accused of overbilling Medicaid, raising concerns about the financial strain on state budgets. The HHS OIG's focus on Medicaid comes amid broader efforts by the Trump administration to root out fraud in government programs, including the Affordable Care Act exchanges. This year, the administration has halted billions in Medicaid funds to states led by Democrats, citing fraud concerns. Furthermore, it has decertified Medicaid fraud units in Hawaii and New York for failing to adequately address fraud in their jurisdictions. As part of its strategy, the administration has introduced a national work requirement for Medicaid, which critics argue could disenfranchise eligible beneficiaries. Looking ahead, the HHS OIG plans to continue its rigorous oversight of Medicare Advantage plans, having already secured settlements with major insurers like Kaiser Permanente and Aetna, which were required to pay $556 million and $117.7 million, respectively, for alleged fraudulent activities. Despite these enforcement actions, concerns remain about the sustainability of Medicare funding as spending in the Medicare Advantage program continues to rise.

Healthcare Dive · 2d ago

Hospital Mergers and Acquisitions Surge in Q2 2026 Amid Financial Pressures

In the second quarter of 2026, hospitals and health systems recorded 18 mergers and acquisitions (M&A), marking one of the highest counts for this period since 2018, according to a report by Kaufman Hall. This surge in activity follows a significant downturn in dealmaking during the first half of 2025, when only eight transactions were reported. The total revenue from these transactions reached $7.7 billion, a dramatic increase from just $1.4 billion in the same quarter last year, highlighting a renewed confidence among healthcare providers in navigating financial challenges. The rebound in M&A activity is attributed to a clearer operational landscape following the passage of significant healthcare legislation in early 2025, which alleviated some of the uncertainty that had previously stalled potential deals. As healthcare organizations face ongoing financial pressures, including rising operating costs and labor expenses, many are proactively seeking partnerships to enhance their capabilities rather than waiting until consolidation becomes necessary. This strategic shift is evident in the types of transactions occurring, with three mega-mergers reported in the quarter, where the smaller party had annual revenues exceeding $1 billion. The trend towards larger mergers reflects a growing inclination among health systems to align with even bigger organizations to better withstand the evolving healthcare environment. Notably, the majority of the second quarter's deals involved nonprofit buyers, with only one transaction led by a for-profit health system. As hospitals continue to grapple with increasing costs—operating margins fell by 4% in May compared to the previous year—this wave of M&A activity is likely to persist as organizations seek to bolster their financial stability and operational efficiency.

Healthcare Dive · 2d ago

Whoop and Kinomatic Launch Pilot Program for Enhanced Recovery Post-Joint Replacement Surgery

Wearable technology company Whoop has partnered with Kinomatic to initiate a 12-week pilot program aimed at improving recovery outcomes for patients undergoing joint replacement surgeries, specifically knee and hip replacements. This innovative program, named Restore, seeks to leverage biometric data to provide enhanced support and insights into patient recovery between medical visits. The pilot will take place across three clinics in California, involving over 100 participants, and aims to demonstrate that a data-informed recovery model can lead to better clinical outcomes, including improved range of motion and reduced reliance on opioids. Currently, patients typically have limited follow-up care after surgery, often only seeing their healthcare providers at two weeks post-operation and attending physical therapy sessions a few times a week. The Restore program intends to bridge this gap by allowing surgeons and patient navigators to monitor key health metrics such as heart rate variability, sleep patterns, and recovery data through Whoop's wrist-based fitness trackers. This real-time data could provide valuable insights into patient progress and help tailor recovery plans more effectively. The pilot's success will be evaluated based on specific metrics, including the range of motion in knee and hip flexion, with assessments occurring at two weeks post-surgery and again after one year. This initiative aligns with a growing trend in the healthcare sector towards integrating wearable technology and biometric monitoring into patient care, particularly in orthopedics. The FDA's recent easing of regulations on certain software features further supports this shift, allowing for more innovative approaches to patient monitoring and recovery management.

Healthcare Dive · 2d ago

Automation Emerges as Essential Strategy for Independent Healthcare Practices

Independent healthcare practices, vital for patient-centered care, are facing unprecedented challenges that threaten their sustainability. Rising operational costs, staffing shortages, complex regulations, and heightened patient expectations have made it essential for these practices to consider automation not just as a technological upgrade, but as a foundational operating model. Automation can alleviate administrative burdens, enhance efficiency, and improve financial performance, allowing practices to maintain the human connections that are central to quality care. Healthcare professionals report that administrative complexity is a significant barrier to practice performance, consuming valuable time and resources. Independent practices, often operating with lean teams, feel this strain acutely, especially when staff turnover occurs. Automation can help by managing repetitive tasks such as appointment scheduling, insurance verification, and claims management, thereby freeing up staff to focus on higher-value activities that require human judgment and empathy. As independent practices navigate financial pressures from reimbursement uncertainties and rising costs, operational efficiency becomes crucial. Automation can standardize processes, accelerate revenue cycles, and minimize errors, ultimately enhancing organizational resilience. Furthermore, as patient expectations evolve towards greater convenience and digital accessibility, automation can facilitate a seamless patient experience without compromising the personal nature of care. In a regulatory landscape that continues to grow in complexity, automation also offers a solution for managing compliance-related processes. By embracing automation, independent practices can not only survive but thrive, ensuring they remain competitive and capable of delivering high-quality care in an increasingly challenging environment.

Healthcare Dive · 2d ago

Memorial Hermann to Wind Down Commercial Insurance Plans Amid Financial Struggles

Memorial Hermann Health Plan, a subsidiary of the Houston-based Memorial Hermann health system, has announced its decision to phase out its commercial insurance offerings due to ongoing financial challenges. The company plans to terminate its employer-based coverage by the end of 2027, with options for customers to renew plans for an additional year if they are set to end before 2026. This move comes as the health system grapples with significant losses, reporting a $250 million deficit in its most recent fiscal year, exacerbated by high operational costs and reimbursement difficulties. Despite a rise in premium revenue from $140.5 million in 2024 to $193.5 million in 2025, Memorial Hermann's expenses related to member care surged from $125.5 million to $163.5 million in the same period. The health system's commercial plans have been operating at a loss, prompting a review of its health plan operations. The decision to wind down its commercial offerings includes the Memorial Hermann Commercial Health Plan, Memorial Hermann Health Insurance Company, and Memorial Hermann Health Solutions. The broader context reveals a trend among integrated health systems, as many are reconsidering their insurance operations amid rising healthcare costs and a shift in patient demographics. With Americans, particularly those in job-based plans, experiencing increased health issues and expenses, insurers are struggling to maintain profitability. This has led to several health systems, including Providence and Baylor Scott & White, exiting their insurance markets. Memorial Hermann will continue to offer its Medicare Advantage plan, which serves approximately 14,000 members, while the future of its commercial plans remains uncertain as the healthcare landscape evolves.

Healthcare Dive · 5d ago

Omnicare Settles $440M Fraud Case with DOJ Amid Bankruptcy Proceedings

Omnicare, a subsidiary of CVS Health, has reached a settlement with the Department of Justice (DOJ) to pay at least $440 million to resolve allegations of fraudulent billing of government healthcare programs. This settlement follows a federal judge's ruling last year that ordered Omnicare to pay nearly $950 million for submitting millions of false claims over an eight-year period. The company subsequently filed for Chapter 11 bankruptcy, citing overwhelming debt. The settlement, while not an admission of liability, is seen as a crucial step in concluding a lengthy legal battle that began over a decade ago when a former pharmacist accused Omnicare of improperly billing Medicare, Medicaid, and Tricare for medications dispensed without valid prescriptions. The DOJ's involvement escalated the case, leading to a jury finding Omnicare liable for fraud. Under the terms of the agreement, CVS is required to pay $130 million to the government within two weeks of finalizing the settlement, with an additional $310 million due by March 2028. This deal is expected to facilitate the sale of Omnicare to GenieRx, a partnership between Milrose Capital and Integro Asset Management, which is anticipated to close later this year. A court hearing regarding the settlement is scheduled for August 12, marking a significant milestone in Omnicare's restructuring efforts and its path towards recovery for creditors.

Healthcare Dive · 5d ago

NHS England Expands Hexarad Rollout for Quicker Scan Results in North East and Yorkshire

NHS England is implementing the Hexarad technology across hospitals in the North East and South Yorkshire to expedite the delivery of scan results to patients. This initiative aims to enhance patient care by reducing wait times for critical diagnostic information, which is essential for timely treatment decisions. The adoption of Hexarad is particularly significant in regions where healthcare resources are stretched, allowing for more efficient use of radiology services. As hospitals integrate this technology, healthcare professionals anticipate improved patient outcomes and satisfaction. The expansion of this program reflects a broader trend towards leveraging technology in healthcare to streamline processes and enhance service delivery.

Digital Health · 5d ago

CVS CEO Confident in Aetna's Cost Management Ahead of Q2 Earnings Report

CVS Health's CEO, David Joyner, expressed optimism regarding Aetna's management of medical costs during a recent event in Washington, D.C. Joyner stated that the insurance division has gained control over healthcare spending projections, a crucial development as CVS prepares to announce its second quarter earnings on August 5. This comes after a challenging period for Aetna, which reported a staggering $984 million operating loss in 2024, a significant drop from the $3.9 billion income in the previous year. The losses were primarily attributed to unexpected cost increases, particularly affecting seniors enrolled in Medicare Advantage plans. In response to these financial challenges, CVS made strategic changes, including reducing benefits and exiting unprofitable markets, which led to a recovery in Aetna's performance with an operating income of $1.8 billion in 2025. Despite these improvements, investor confidence remains cautious due to ongoing uncertainties in healthcare policy and the unpredictable nature of medical spending trends post-pandemic. Joyner emphasized the importance of accurately forecasting costs and has actively engaged with lawmakers to address the drivers of healthcare expenses. As CVS approaches its earnings report, the company has raised its revenue and earnings guidance, reflecting a positive outlook. However, Joyner highlighted that the primary challenge lies not in managing costs for members but in navigating the complex policy landscape that affects the healthcare industry. The upcoming earnings report will be closely watched by investors and analysts for indications of Aetna's continued recovery and CVS's overall financial health.

Healthcare Dive · 6d ago

Aneurin Bevan University Health Board Launches Better Meds ePMA System

Aneurin Bevan University Health Board has initiated the implementation of the Better Meds electronic prescribing and medicines administration (ePMA) system. This rollout aims to enhance medication safety and streamline the prescribing process within the healthcare setting. The Better Meds system is designed to reduce medication errors, improve patient outcomes, and facilitate better communication among healthcare providers. As the health board adopts this technology, it is expected to positively impact both clinical staff and patients by ensuring more accurate and efficient medication management. The transition to this new system is part of a broader effort to modernize healthcare delivery and improve overall patient care in the region.

Digital Health · 6d ago

Centene to Withdraw from Arkansas Medicaid Expansion Program Amid Funding Challenges

Centene Corporation has announced its decision to exit Arkansas' Medicaid expansion program, known as ARHOME, by 2027, citing significant funding challenges as the primary reason. This program, established under the Affordable Care Act in 2013, provides coverage to approximately 77,000 Arkansans aged 19 to 64 with incomes up to 138% of the federal poverty level. The withdrawal is particularly noteworthy as it reflects broader trends among Medicaid insurers reassessing their participation in state programs due to impending work requirements and funding cuts. The decision comes in the wake of nearly $1 trillion in cuts to Medicaid over the next decade, stemming from recent legislative changes that impose work, volunteer, or educational requirements on expansion adults. Analysts have pointed out that while these policies aim to promote employment, they may inadvertently lead to increased administrative burdens and coverage losses for eligible individuals. Arkansas previously attempted to implement similar work requirements in 2018, resulting in significant coverage losses before being blocked by a federal judge. With Centene's exit, Arkansas Blue Cross and Blue Shield will remain the sole insurer in the ARHOME program, raising concerns about the continuity of care for affected enrollees. Centene will continue to provide Medicaid managed care for non-expansion populations and other health plans in the state. This move is part of a larger trend where insurers are reevaluating their market strategies, with several companies, including Aetna and Cigna, also withdrawing from various health insurance markets due to financial pressures. As Arkansas prepares to implement new compliance checks for work requirements, it is estimated that around 42,000 Medicaid enrollees could lose their coverage. The implications of Centene's departure and the new work requirements could lead to further instability in the state's healthcare landscape, necessitating close monitoring of the situation as it develops.

Healthcare Dive · Jul 8

NHS England's Registration Expectation Marks a Turning Point for Digital Health Professionals

Andrew Griffiths, the chief executive of the Federation for Digital Health Professionals (FEDIP), has emphasized the significance of NHS England's new expectation regarding the registration of digital health professionals. This initiative is seen as a pivotal moment for the digital health sector, as it aims to enhance the standards and accountability within the profession. Griffiths argues that this move will require professionals in the digital health space to operate at the highest level of competency and ethics, ensuring that they meet the evolving demands of healthcare delivery. The registration expectation is designed to establish a framework that promotes best practices and fosters trust among patients and healthcare providers. By mandating registration, NHS England aims to create a more regulated environment that can improve the quality of digital health services. This is particularly important as the integration of technology in healthcare continues to expand, necessitating a workforce that is not only skilled but also accountable. Healthcare professionals, particularly those involved in digital health, will be directly affected by this new requirement. It is anticipated that the registration process will encourage ongoing professional development and adherence to industry standards. Griffiths highlights that this initiative could lead to better patient outcomes and a more robust digital health ecosystem. Looking ahead, the implementation of this registration expectation will likely prompt discussions around the necessary qualifications and training for digital health professionals. As the healthcare landscape evolves, it will be crucial for stakeholders to engage in dialogue about the future of digital health and the role of regulation in ensuring its success.

Digital Health · Jul 8

NHS Staff Risk Dismissal or Legal Action for Unlawful Patient Data Access

NHS England's chief executive, Sir Jim Mackey, has issued a stern warning to NHS staff regarding the unauthorized access of patient records. He emphasized that such actions could lead to severe consequences, including termination of employment or even imprisonment. This statement underscores the importance of patient confidentiality and the legal obligations healthcare professionals have to protect sensitive information. The move aims to reinforce the trust patients place in the NHS and ensure compliance with data protection regulations. As healthcare systems increasingly rely on digital records, safeguarding patient data remains a critical priority for the NHS and its workforce.

Digital Health · Jul 8

Audit Confirms Validity of UnitedHealth's Home Visit Diagnoses Amid Ongoing Scrutiny

A recent audit conducted by FTI Consulting has found that 96.6% of diagnoses made during UnitedHealth's HouseCalls program for Medicare seniors are supported by medical records. This finding counters allegations that the program inflates patient diagnoses to increase federal reimbursements. The audit reviewed a random sample of 200 home visits, identifying only 3.4% of diagnoses as unsupported, a significantly lower error rate compared to previous audits by the Centers for Medicare & Medicaid Services (CMS). UnitedHealth has defended the HouseCalls program, emphasizing its role in providing preventive care and understanding the comprehensive health needs of seniors. However, critics remain concerned that such in-home assessments may enable insurers to exaggerate diagnoses, thereby increasing their reimbursement rates. A government investigation in 2024 revealed that major Medicare Advantage (MA) insurers, including UnitedHealth, received billions in overpayments linked to questionable diagnoses from health risk assessments. In 2023 alone, UnitedHealth received $3.7 billion from in-home health assessments, raising further scrutiny over its practices. In response to the audit findings and ongoing investigations, UnitedHealth's CEO Stephen Hemsley has committed to enhancing transparency and integrity within the company's operations. He announced that the company has implemented all 23 recommendations from previous audits, including establishing an independent team to oversee coding and risk assessment practices. Hemsley also indicated that further details regarding the HouseCalls program will be shared publicly in the near future, as the company aims to address concerns and improve its practices.

Healthcare Dive · Jul 7

University Hospitals of Leicester Enhances EPR System and Initiates Ambient Voice Technology Deployment

University Hospitals of Leicester has successfully upgraded its Nervecentre electronic patient record (EPR) system, marking a significant advancement in its digital healthcare capabilities. This upgrade is part of a broader initiative to improve patient care and streamline clinical workflows. In conjunction with the EPR enhancement, the hospital has also commenced a phased rollout of ambient voice technology (AVT), which is expected to further enhance documentation processes and reduce administrative burdens on healthcare professionals. The implementation of AVT is particularly noteworthy as it aims to facilitate real-time clinical documentation through voice recognition, allowing clinicians to focus more on patient interaction rather than manual data entry. This technology is anticipated to improve efficiency and accuracy in patient records, ultimately leading to better patient outcomes. Healthcare professionals and administrative staff at University Hospitals of Leicester will be directly affected by these upgrades, as they will need to adapt to the new systems and workflows. The integration of AVT into daily operations is expected to be a gradual process, with training and support provided to ensure a smooth transition. As the rollout progresses, the hospital will monitor the impact of these technologies on clinical efficiency and patient satisfaction. Future updates on the effectiveness of the EPR system and AVT will be crucial in determining the long-term benefits of these innovations in the healthcare setting.

Digital Health · Jul 7

Epic's President Sumit Rana to Depart This Summer After Nearly 30 Years

Sumit Rana, the president of Epic, the largest electronic health record (EHR) vendor in the U.S., has announced his resignation effective August 14, 2023. After nearly three decades with the company, Rana is stepping down to spend more time with his family following the passing of his father last November. His departure marks a potential leadership transition for Epic, as he was considered a strong candidate to succeed CEO Judy Faulkner, who is 82 years old. Rana joined Epic in 1998 and has played a pivotal role in the company's growth, including the development of MyChart, Epic's patient portal. Under his leadership, Epic has also focused on advancing artificial intelligence (AI) tools and enhancing health data sharing capabilities. In a recent interview, he expressed pride in the company's innovations, particularly the launch of AI charting products that assist clinicians during patient appointments. Epic currently holds a dominant position in the hospital EHR market, controlling approximately 44% of acute care hospitals as of last year, according to Klas Research. The company has been actively expanding its AI offerings, including tools like Art for clinicians and Penny for revenue cycle management. Following Rana's departure, a group of leaders he mentored will assume additional responsibilities, ensuring continuity in Epic's leadership and commitment to fostering new talent within the organization.

Healthcare Dive · Jul 6

Isle of Man Health Minister Advocates for Revolutionary Single Patient Record System

The Isle of Man's health minister has announced plans to implement a single patient record system, describing it as a 'revolutionary' advancement in healthcare. This initiative aims to streamline patient data management, improve care coordination, and enhance the overall efficiency of healthcare services on the island. By consolidating patient information into a single, accessible record, healthcare providers can ensure that they have the most up-to-date information at their fingertips, which is crucial for delivering timely and effective care. The introduction of a single patient record is expected to significantly benefit both healthcare professionals and patients. For providers, it reduces the risk of errors associated with fragmented records and facilitates better communication among different healthcare teams. For patients, it means that their medical history, treatment plans, and other critical information will be readily available, leading to improved health outcomes. This initiative is particularly important in the context of increasing demands on healthcare systems and the need for more integrated care approaches. As the Isle of Man moves forward with this project, stakeholders will be closely monitoring its implementation and impact on patient care. The health minister's vision reflects a broader trend in healthcare towards digital transformation and the use of technology to enhance patient experiences and outcomes.

Digital Health · Jul 6

Healthcare Construction Timelines: A New Operational Risk for Providers

Healthcare systems are increasingly facing operational risks due to the challenges of construction timelines. As demand for expanded services and modernized facilities grows, traditional construction methods are proving less reliable, primarily due to labor shortages in skilled trades. This situation complicates project staffing and scheduling, forcing healthcare organizations to balance ongoing patient care with the need for facility upgrades. Delays in construction can lead to postponed patient services, deferred revenue, and extended temporary leasing arrangements, all of which impact capital planning and operational efficiency. To mitigate these risks, healthcare organizations are turning to permanent modular construction as a viable solution. This method allows for much of the building process to occur offsite in a controlled environment, enabling parallel construction where site preparation and fabrication happen simultaneously. This approach not only enhances schedule reliability by minimizing exposure to labor and weather-related delays but also ensures that the structures meet the same building codes and performance standards as traditionally constructed facilities. The benefits of modular construction extend beyond just timelines; they also significantly reduce onsite disruptions, which is crucial for active healthcare environments. By minimizing noise, dust, and congestion, modular construction helps maintain a safe and functional space for both patients and staff during the building process. As healthcare demands continue to rise, solutions like CareAffirm's modular room offerings are essential for supporting operational continuity while enabling facility expansion. Ultimately, faster project completion translates to earlier patient care delivery and improved financial outcomes for healthcare providers.

Healthcare Dive · Jul 6

NHS Launches Integrated Ambient Voice Technology with £10 Billion Tech Investment

NHS England has announced the rollout of integrated ambient voice technology (AVT) as part of a significant £10 billion investment in health technology. This initiative aims to enhance patient care and streamline operations within the healthcare system by leveraging artificial intelligence tools. The integration of AVT is expected to improve communication between healthcare providers and patients, facilitating better data collection and patient monitoring. The decision to implement AVT comes at a crucial time when the NHS is seeking innovative solutions to address ongoing challenges such as staff shortages and increasing patient demand. By incorporating AI-driven tools, the NHS hopes to optimize workflows, reduce administrative burdens, and ultimately improve patient outcomes. Healthcare professionals, including doctors and nurses, will be directly affected by this technology as it is designed to assist them in their daily tasks. The deployment of AVT is anticipated to enhance the efficiency of patient interactions, allowing for more time to focus on clinical care. As the NHS moves forward with this initiative, stakeholders will be closely monitoring its impact on both healthcare delivery and patient satisfaction. Looking ahead, the NHS plans to evaluate the effectiveness of AVT and other AI tools as part of its broader strategy to modernize healthcare services. This rollout represents a significant step towards integrating advanced technology into the NHS framework, with the potential for further innovations in the future.

Digital Health · Jul 4

Decline in Reported Information Blocking by Health Information Exchanges: ONC Data Analysis

A recent report from the Office of the National Coordinator for Health Information Technology (ONC) indicates a significant decline in the instances of information blocking reported by health information exchange (HIE) organizations. In 2019, over 90% of HIEs reported experiencing potential information blocking, but by 2025, this figure had decreased to 71%. This reduction suggests that while fewer organizations may be engaging in these practices, a small number of entities continue to block the flow of health data regularly. The 21st Century Cures Act, enacted in 2016, aimed to eliminate barriers to health information exchange, with regulations against information blocking taking effect in 2021. Despite the progress, the ONC report highlights that a significant portion of HIEs still perceive information blocking as a concern, particularly among IT developers. Over 60% of HIEs reported that IT developers sometimes or routinely hindered data sharing, a decrease from over 80% in 2019. The report also notes that while the overall perception of information blocking has improved, the frequency of such practices among certain organizations remains unchanged. Approximately one-third of HIEs indicated that information blocking by IT companies was routine, and 20% reported frequent blocking by hospitals and health systems. This persistent issue raises questions about the effectiveness of current regulations and the need for stricter enforcement. As the federal government prepares to take action against entities that impede health data sharing, including potential penalties for non-compliance, the ONC's findings could influence future policymaking. The focus will likely shift towards deterring the small group of organizations that continue to engage in information blocking, which could significantly enhance the overall health information exchange landscape.

Healthcare Dive · Jul 2

Medicare Advantage Quality Bonuses Surpass $13 Billion Amid Enrollment Decline

The Medicare Advantage (MA) program is projected to distribute over $13 billion in quality bonus payments this year, according to a recent analysis by the Kaiser Family Foundation (KFF). This marks a significant increase from $12.7 billion in 2025 and represents a fourfold rise from the $3 billion allocated in 2015. Despite this surge in spending, the percentage of Medicare beneficiaries enrolled in plans eligible for these bonuses has decreased, falling from 75% to 68%, with only 24 million seniors in qualifying plans for 2026, the lowest share since 2018. The quality bonus program, initiated by the Affordable Care Act in 2010, rewards MA plans with ratings of four stars or higher, incentivizing insurers to enhance customer engagement and outcomes. However, the program has faced scrutiny from budget analysts and health policy experts who argue that the star ratings system is overly complex and may not accurately reflect plan quality. Calls for reform or elimination of the program have intensified, with estimates suggesting that abolishing it could save the federal government nearly $100 billion over a decade. Currently, over half of Medicare enrollees, approximately 35 million seniors, participate in the privatized MA program, which has seen a rise in spending due to increased enrollment and underlying Medicare costs. Despite the decline in eligible enrollees, the quality bonus payments continue to grow, driven by changes in the star ratings system and the financial pressures facing Medicare. The Centers for Medicare & Medicaid Services (CMS) recently finalized changes that could result in an additional $18 billion in payments to insurers over the next decade, further complicating the financial landscape. Major players in the MA market, such as UnitedHealth and Humana, are positioned to benefit significantly from these bonuses, with UnitedHealth expected to receive approximately $3.9 billion, accounting for 29% of total quality bonus spending. In contrast, Humana's share has diminished due to a drop in star ratings for one of its major contracts. As policymakers grapple with the sustainability of Medicare funding, the future of the quality bonus program remains uncertain, especially as insurers continue to advocate for its retention amidst ongoing financial challenges.

Healthcare Dive · Jul 2

Midlands NHS Organizations Receive £85 Million Investment to Enhance Obesity Care

Health Innovation West Midlands (HIWM) has successfully facilitated local NHS organizations in securing a portion of the £85 million national funding aimed at transforming obesity care. This significant investment is part of a broader initiative to address the rising obesity epidemic, which poses serious health risks and economic burdens on the healthcare system. The funding will enable the implementation of innovative programs and services designed to improve patient outcomes and promote healthier lifestyles among the population. As obesity rates continue to climb, this investment is crucial for enhancing the quality of care and support available to affected individuals. Moving forward, stakeholders will focus on developing effective strategies to utilize these funds efficiently and measure the impact on obesity management in the region.

Digital Health · Jul 2

Digital Health Briefing: Advancements in Medical Cannabis Accreditation and Musculoskeletal Rehabilitation

In today's digital health briefing, significant developments were highlighted regarding medical cannabis accreditation and innovative systems aimed at enhancing musculoskeletal performance and rehabilitation. The accreditation of medical cannabis is crucial as it ensures that products meet safety and efficacy standards, which is essential for healthcare providers and patients alike. This accreditation process is expected to improve patient access to quality cannabis products, thereby potentially increasing its therapeutic use in various conditions. Additionally, advancements in systems designed to improve musculoskeletal performance are gaining attention. These systems focus on rehabilitation techniques that can enhance recovery outcomes for patients with musculoskeletal injuries. By integrating technology into rehabilitation practices, healthcare professionals can offer more personalized and effective treatment plans, ultimately leading to better patient outcomes. These developments are particularly relevant for healthcare providers involved in pain management, rehabilitation, and sports medicine. As the landscape of digital health continues to evolve, staying informed about these advancements is vital for practitioners aiming to provide the best care possible. The next steps will likely involve further research and implementation of these systems in clinical settings, as well as ongoing discussions about the regulatory frameworks surrounding medical cannabis.

Digital Health · Jul 2

Sheffield City Council Opposes NHS Contract with Palantir

Sheffield City Council has made history by becoming the first local authority to formally oppose the NHS's contract with Palantir Technologies for the Future Data Platform (FDP). This decision reflects growing concerns regarding data privacy and the ethical implications of using private companies in public health initiatives. The council's motion highlights the potential risks associated with Palantir's data handling practices and calls for greater transparency in how patient data is managed within the NHS. This opposition may set a precedent for other councils and local authorities across the UK, as they evaluate the implications of similar partnerships. As the debate continues, stakeholders in the healthcare sector will need to address these concerns while balancing the need for innovative data solutions in public health.

Digital Health · Jul 2

Understanding the Impact of Digital Biomarkers in Healthcare

Digital biomarkers are emerging as a transformative element in healthcare, leveraging technology to enhance patient monitoring and treatment outcomes. These biomarkers, which include data collected from wearable devices and mobile health applications, provide real-time insights into a patient's health status. This shift towards digital health is significant as it allows for more personalized and timely interventions, potentially improving patient adherence to treatment plans and overall health management. The relevance of digital biomarkers is underscored by their ability to capture a wide array of health data, from physical activity levels to physiological parameters such as heart rate and sleep patterns. This data can be crucial for chronic disease management, where continuous monitoring can lead to early detection of complications and timely adjustments in treatment. For instance, patients with diabetes can benefit from continuous glucose monitoring systems that provide real-time feedback, enabling better glycemic control. Healthcare professionals, including physicians and researchers, are increasingly recognizing the potential of digital biomarkers to enhance clinical decision-making. However, the integration of these technologies into standard practice raises questions about data privacy, regulatory standards, and the need for robust validation studies to ensure their efficacy and reliability. As the field evolves, stakeholders must address these challenges to fully harness the benefits of digital biomarkers. Future developments may include improved algorithms for data analysis and enhanced interoperability between devices and healthcare systems, paving the way for a more connected and responsive healthcare environment.

The Medical Futurist · Jul 2

NHS Greater Glasgow and Clyde Launches Digital Triage System in Emergency Departments

NHS Greater Glasgow and Clyde (NHSGGC) has initiated the implementation of a digital triage system aimed at enhancing patient care in its emergency departments. This innovative system is designed to streamline the triage process, allowing for more efficient patient assessment and prioritization based on the severity of their conditions. The rollout is expected to improve patient flow and reduce waiting times, which have been critical issues in emergency care settings. The introduction of this digital system is significant as it addresses ongoing challenges faced by emergency departments, particularly in managing high patient volumes and ensuring timely care. By utilizing technology, NHSGGC aims to optimize resource allocation and improve overall patient outcomes. This initiative is part of a broader strategy to modernize healthcare delivery and integrate digital solutions into everyday clinical practices. Healthcare professionals and administrators are closely monitoring the implementation process, as its success could serve as a model for other health systems facing similar challenges. Key performance indicators will likely include reductions in wait times and improved patient satisfaction scores. As NHSGGC continues to roll out this system, further evaluations will be conducted to assess its impact on emergency care efficiency and patient safety.

Digital Health · Jul 1

NHS Digital Academy's James Freed Advocates for Strategic Investment in Digital Health Solutions

James Freed, the deputy director of the NHS Digital Academy, has emphasized the untapped potential of digital health solutions in the NHS. He argues that the current approach to digital investments often leads to wasted resources, suggesting that a more strategic focus could yield significant benefits for healthcare delivery. Freed's insights highlight the importance of leveraging technology to enhance patient care and streamline operations within the NHS. As healthcare systems worldwide increasingly turn to digital solutions, understanding how to effectively implement these technologies is crucial for improving outcomes and efficiency. The NHS must prioritize thoughtful investments in digital health to avoid financial losses and maximize the advantages that technology can offer.

Digital Health · Jul 1

Isle of Man Announces Winners of 2026 Innovation Challenge for Health and Social Care Solutions

The Isle of Man has revealed the winners of its 2026 Innovation Challenge, aimed at fostering advancements in health and social care. Four companies have been recognized for their innovative solutions that promise to enhance the quality of care and improve health outcomes for the community. This initiative is significant as it highlights the importance of innovation in addressing the evolving needs of healthcare systems, particularly in the context of an aging population and increasing demand for services. The selected companies will likely play a crucial role in shaping future healthcare practices on the Isle of Man, potentially serving as models for similar initiatives elsewhere. As these innovations are implemented, stakeholders will be closely monitoring their impact on health and social care delivery.

Digital Health · Jul 1

26 States Challenge Medicaid Work Requirements in Lawsuit Against Trump Administration

Twenty-six states have initiated legal action against the Trump administration, contesting new Medicaid work requirements established by the Centers for Medicare & Medicaid Services (CMS). The lawsuit, filed in federal court, claims that the recent interim final rule diverges significantly from the original provisions set forth in the 'Big Beautiful Bill,' which introduced these work requirements. The states argue that the new regulations could jeopardize coverage for vulnerable enrollees and impose undue administrative burdens on state Medicaid programs. The interim final rule mandates that Medicaid expansion enrollees must log 80 hours of work, volunteer, or educational service monthly to maintain their coverage. However, the states assert that the CMS has narrowed the definition of 'medically frail,' making it more challenging for individuals with serious health conditions to qualify for exemptions from these requirements. This change could particularly affect patients undergoing treatment for chronic illnesses, disabilities, or other complex health issues. Research indicates that a significant portion of Medicaid enrollees at risk of disenrollment have multiple chronic conditions, highlighting the potential impact of these regulatory changes. The states involved, including Massachusetts, California, and New Jersey, contend that the CMS's actions violate the Administrative Procedure Act and impose unclear requirements that could lead to chaos in Medicaid administration. As the lawsuit progresses, the states are seeking a court order to pause the implementation of the work requirements while the legal challenges are addressed. This case underscores the ongoing tensions between state and federal regulations regarding Medicaid and the implications for millions of enrollees who rely on this safety-net program for their healthcare needs.

Healthcare Dive · Jun 30

ONC Enhances Oversight of TEFCA Amid Surge in Health Data Exchange

The Office of the National Coordinator for Health Information Technology (ONC) has announced new oversight measures for the Trusted Exchange Framework and Common Agreement (TEFCA) as the volume of health records exchanged through the framework has surged. A contract worth $1.3 million has been awarded to Alliance Global Tech, a Maryland-based IT consulting firm, to ensure compliance with TEFCA's policies and procedures. This initiative comes as the number of health records exchanged has skyrocketed from approximately 10 million in January 2025 to over 1 billion by mid-2026. TEFCA, which was launched in 2023, serves as a nationwide governance framework for health data exchange, facilitating connections between health systems, hospitals, and public health agencies through Qualified Health Information Networks (QHINs). The number of approved QHINs has also increased from five at launch to eleven, with notable participants including eClinicalWorks, Netsmart, Oracle Health, and Surescripts. The ONC's new contract with Alliance Global Tech is part of a broader strategy to enhance oversight and ensure that the data exchanged meets quality and security standards. Dr. Thomas Keane, the national coordinator for health IT, emphasized the importance of secure data exchange for improving clinical outcomes. The ONC is also taking steps to address information blocking, with potential sanctions for companies that impede the flow of health information. This regulatory focus on interoperability is underscored by a recent lawsuit involving Epic, the largest electronic health record vendor, which highlights ongoing challenges in the health data exchange landscape. As the ONC continues to refine its oversight, the future of health data interoperability remains a critical area of focus for healthcare professionals and organizations.

Healthcare Dive · Jun 29

Microsoft's Dragon Copilot Enhances AI Integration in Healthcare for Improved Patient Care

In a significant advancement for healthcare technology, Microsoft has introduced Dragon Copilot, a unified AI clinical assistant designed to streamline workflows and enhance patient care. As healthcare organizations increasingly adopt AI solutions, the focus has shifted from whether to implement these tools to how quickly they can be integrated effectively. Kenneth Harper, general manager of Dragon product management at Microsoft, emphasizes the importance of equipping healthcare teams with scalable tools that assist across various roles while minimizing administrative burdens. Dragon Copilot allows healthcare providers to access a range of partner-built applications through the Microsoft Marketplace, addressing common challenges in the industry. One notable integration is with Regard, a proactive documentation platform that analyzes electronic health records to recommend potentially missed diagnoses. Dr. David Kirk, chief medical officer for Regard, highlights the platform's ability to provide real-time information, enabling clinicians to make informed decisions at critical moments. This integration not only enhances the quality of care but also allows physicians to spend more time with patients. Regard has already made a significant impact, having recommended over 14 million diagnoses that may have otherwise gone unnoticed. Its seamless integration into Dragon Copilot means that thousands of clinicians across 150 hospitals can utilize its capabilities without disrupting their existing workflows. The potential for AI to improve clinical outcomes is substantial, as it supports quality scores, reimbursement processes, and overall patient satisfaction. As healthcare continues to evolve, the integration of AI tools like Dragon Copilot and its partner applications is expected to transform medical practice. With additional tools available through the Marketplace, such as Canary for mental health assessment and Humata for prior authorization, healthcare organizations can further reduce administrative burdens and enhance patient-centered care. The future of healthcare is increasingly reliant on trusted AI partnerships that improve operational efficiency and patient outcomes.

Healthcare Dive · Jun 29

Quality Metrics Essential for Cost Management in Healthcare Delivery

The healthcare industry is facing a significant challenge as medical cost trends are projected to reach a median of 9% for 2026, the highest in over a decade. This increase is largely attributed to elevated utilization rates post-pandemic and rising specialty drug costs, particularly GLP-1 medications, which accounted for nearly a third of last year's drug spending growth. As health plans narrow networks and intensify utilization management, employers are feeling the financial squeeze, with members taking on substantial cost-sharing. A critical issue is that the party incurring costs often does not control them. For instance, self-funded employers bear the claims risk but only see the financial impact after care is delivered. The current healthcare model incentivizes providers to increase services without a focus on quality, leading to significant variations in care decisions. Research shows that provider choices influence approximately 80% of healthcare spending, highlighting the importance of measuring and improving provider-level quality. Embold Health's methodology reveals stark disparities in surgical rates for similar conditions, with differences exceeding a factor of 30 between conservative and interventional providers. Such variations can lead to unnecessary surgeries, costing tens of thousands of dollars and exposing patients to avoidable complications. Despite the availability of data, it has historically been used for retrospective accountability rather than guiding patient choices at the point of care. To address these challenges, the industry must shift towards using quality metrics proactively, informing members' decisions before care is delivered. This requires a reconfiguration of provider directories and network designs to prioritize clinical excellence over geographical convenience or cost. By aligning all stakeholders around a shared definition of quality, the healthcare system can improve outcomes, reduce unnecessary costs, and enhance the overall patient experience.

Healthcare Dive · Jun 29

NHS Underutilizes AI for Administrative Efficiency, RCR Workforce Census Reveals

Recent data from the Royal College of Radiologists (RCR) indicates that the National Health Service (NHS) is not fully leveraging artificial intelligence (AI) to enhance productivity, particularly in administrative tasks. The findings suggest that there is significant potential for AI to streamline operations and reduce workloads for healthcare professionals, which could lead to improved patient care and operational efficiency. The underutilization of AI tools in the NHS raises concerns about missed opportunities for enhancing service delivery and optimizing resource allocation. As the healthcare sector continues to evolve, it is crucial for organizations to explore and implement AI solutions that can alleviate administrative burdens and allow staff to focus more on patient-centered care. Moving forward, stakeholders within the NHS may need to prioritize the integration of AI technologies to realize these productivity gains and improve overall healthcare outcomes.

Digital Health · Jun 29

Aidoc Secures FDA Breakthrough Designation for AI-Powered Chest X-Ray Analysis

Aidoc has been granted the FDA's breakthrough device designation for its innovative AI feature, First Read, which is designed to analyze chest X-rays and produce preliminary reports on over 100 specified findings. This development, announced on June 26, 2026, aims to streamline the reporting process for radiologists, significantly reducing the time they spend on interpretation. Although the AI system generates draft reports, a radiologist's signature is still required for each report, ensuring that human oversight remains integral to the diagnostic process. The breakthrough designation from the FDA is crucial as it prioritizes the review of devices that offer significant advancements in the treatment or diagnosis of serious conditions. Aidoc's technology builds on its existing applications that triage findings from CT scans, indicating a robust commitment to enhancing radiological efficiency. The company has raised $150 million in funding to further develop its AI capabilities and is currently utilized in over 2,000 hospitals globally. This milestone comes at a time when the medical device industry is increasingly exploring the potential of generative AI technologies. Recently, UpDoc received FDA clearance for a patient-facing device that leverages large language models to assist in patient management, showcasing the growing intersection of AI and healthcare. However, the FDA has yet to establish a comprehensive regulatory framework for generative AI, despite ongoing discussions and draft guidance aimed at ensuring transparency and mitigating bias in AI applications. As Aidoc prepares to bring First Read to market, the implications for radiology and patient care could be significant, potentially transforming how diagnostic imaging is approached in clinical settings.

Healthcare Dive · Jun 26

Surge in Patient Messaging to Providers Highlights Shift in Healthcare Communication

A recent study published in JAMA reveals a significant increase in patient messages to healthcare providers, rising by 153% from 2020 to 2025. This surge coincides with a 17% increase in office visits, indicating that messaging is enhancing communication rather than replacing in-person consultations. The findings suggest that while patients are gaining greater access to their clinicians through digital portals, this trend may also lead to increased workloads for healthcare providers. The study analyzed data from over 2,000 hospitals and 47,000 clinics, showing that the average number of messages sent by patients rose from 0.99 to 2.5 messages per patient per year during the study period. The rise in patient messaging is particularly notable among women and individuals aged 40 to 64, as well as those in neighborhoods with fewer social vulnerabilities. Concurrently, clinician-authored messages also increased by 24%, from 4.59 to 5.7 messages per clinician. The peak of messaging activity occurred in 2021 during the pandemic, highlighting a structural shift in communication practices within healthcare. Despite the increase in digital communication, the study found that in-person visits have not declined significantly, suggesting that patients still value face-to-face interactions with their healthcare providers. However, the growing volume of messages may pose challenges for clinicians, contributing to administrative burdens and potential burnout. Experts suggest that artificial intelligence tools could alleviate some of these pressures by streamlining communication tasks and improving efficiency in healthcare settings. As health systems adapt to these changes, addressing engagement gaps among underserved populations will be crucial for equitable care delivery.

Healthcare Dive · Jun 25

Implications of Andy Burnham's Potential Premiership on NHS IT Investment

As discussions around the potential premiership of Andy Burnham gain momentum, healthcare professionals are considering the implications for NHS IT investment. Jon Hoeksma analyzes the perspectives of former health secretaries, including Burnham and Wes Streeting, on the future of digital health initiatives within the National Health Service (NHS). With the NHS facing ongoing challenges in digital transformation, the leadership of Burnham could signal a renewed focus on enhancing IT infrastructure and funding. This is particularly significant as the NHS seeks to improve patient care through technology, streamline operations, and address the growing demand for digital services. Stakeholders in the healthcare sector are closely monitoring these developments, as they could shape the trajectory of NHS IT investments and influence the overall effectiveness of healthcare delivery in the UK.

Digital Health · Jun 25

NIHR Funds AI Studies to Address NHS Waiting Times in £8 Million Initiative

The National Institute for Health and Care Research (NIHR) has allocated funding for two innovative studies aimed at utilizing artificial intelligence (AI) to alleviate the persistent issue of NHS waiting times. This initiative is part of a broader £8 million investment in AI research, reflecting a growing recognition of technology's potential to enhance healthcare delivery. The studies are expected to explore various AI applications that could streamline processes, improve patient flow, and ultimately reduce delays in treatment. This funding is particularly significant as NHS waiting times have reached critical levels, impacting patient care and outcomes across the UK. By integrating AI solutions, the studies aim to provide actionable insights and tools that can be implemented within the NHS framework. The outcomes of these studies could set a precedent for future AI applications in healthcare, potentially transforming how services are delivered. Healthcare professionals and policymakers will be closely monitoring the progress of these studies, as successful implementation could lead to widespread changes in operational efficiency within the NHS. As the healthcare landscape continues to evolve, the integration of AI may become a cornerstone in addressing systemic challenges such as waiting times, thereby improving overall patient satisfaction and care quality.

Digital Health · Jun 25

U.S. Healthcare Spending Reaches $5.7 Trillion Amid Rising Drug Costs and Policy Changes

U.S. healthcare spending surged by 7.3% last year, reaching $5.7 trillion, primarily driven by increased utilization of hospital services and high-cost prescription drugs, particularly GLP-1s. This growth is not attributed to rising prices but rather to a rebound in healthcare consumption following the COVID-19 pandemic. CMS actuaries noted that while spending growth was unexpected, it reflects a broader trend of escalating healthcare costs that outpace overall economic growth. The forecast indicates that retail prescription drug spending will continue to rise sharply, especially for GLP-1s, which are increasingly prescribed for weight loss despite their high monthly costs of around $1,000. Approximately one in eight Americans are reported to be using these medications, contributing significantly to the overall increase in health spending. The CMS anticipates that health spending will account for over 20% of the U.S. GDP by 2034, highlighting the growing financial burden on the economy. Policy changes, including cuts to Medicaid and the expiration of ACA subsidies, are expected to further impact the insurance landscape and spending patterns. The insured population is projected to decline from 91.8% in 2024 to 90.5% by 2034, raising concerns about access to care and the financial implications for both patients and the healthcare system. As lawmakers prepare for upcoming elections, the CMS's findings underscore the urgent need for effective strategies to manage healthcare costs and improve outcomes in a system that spends significantly more than other wealthy nations while lagging in key health metrics.

Healthcare Dive · Jun 24

FDA Rescinds Warning Letter to Whoop on Blood Pressure Feature After Modifications

The FDA has officially rescinded its warning letter to Whoop, a wearable device company, regarding its blood pressure feature. This decision follows modifications made by Whoop to align with the FDA's updated guidance on wearable health technologies. The closeout letter, released on Tuesday, indicates that the FDA will not enforce device requirements on the revised version of Whoop's blood pressure feature, which is now categorized under wellness rather than medical device regulations. This regulatory shift is significant as it reflects the FDA's evolving stance on the classification of health metrics provided by wearable devices. Previously, in July, the FDA had raised concerns about the blood pressure feature, suggesting that it could be interpreted as a medical diagnostic tool. However, the agency's January guidance clarified that blood pressure measurements intended for wellness purposes do not require the same level of oversight as medical devices. Whoop's blood pressure insights feature, launched last year, estimates daily systolic and diastolic blood pressure based on heart rate and blood flow patterns during sleep. Following the warning letter, Whoop made adjustments to the feature to ensure it would not be misinterpreted as a clinical measurement. CEO Will Ahmed emphasized the importance of scientific integrity and the company's commitment to its users in his response to the FDA's initial concerns. Looking ahead, Whoop plans to collaborate with the FDA as it develops more regulated medical technologies, signaling a proactive approach to compliance and innovation in the wearable health tech space.

Healthcare Dive · Jun 24

NHS Leaders Announced as Speakers for Summer Schools 2026 on Digital Health

The upcoming Summer Schools 2026, scheduled for July 16-17, will feature prominent national leaders from the NHS who are instrumental in advancing digital health initiatives. This event aims to bring together healthcare professionals and stakeholders to discuss the future of digital health and its implications for patient care and healthcare delivery. The inclusion of these leaders underscores the NHS's commitment to integrating technology into healthcare systems, which is increasingly vital in today's rapidly evolving medical landscape. Attendees can expect insights into the latest trends, challenges, and opportunities in digital health, making this a significant event for those involved in healthcare innovation and policy. As the healthcare sector continues to adapt to technological advancements, the discussions at Summer Schools 2026 will be crucial for shaping future strategies and practices.

Digital Health · Jun 24